Bromhexine is a mucolytic agent classified under respiratory-system drugs. It is available in pill form with a strength of 8 mg per tablet. In Hong Kong, bromhexine is a prescription-only medication regulated by the Department of Health. The active ingredient, bromhexine hydrochloride, works by thinning mucus, making it easier to clear from the airways.
Bromhexine helps improve airway clearance through several actions:
These combined effects lead to a faster and more effective expectoration of sputum, assisting patients who have trouble clearing respiratory secretions.
Bromhexine is approved in Hong Kong for the symptomatic relief of:
While it is categorized under “Asthma & Breathing,” bromhexine is not a bronchodilator and is not indicated for asthma control. Its role is limited to improving mucus clearance, which can be helpful in patients with asthma who also experience mucus hypersecretion.
Current peer-reviewed literature does not provide strong evidence for routine off-label use of bromhexine beyond its mucolytic indication. Any consideration of alternative applications should be made only under direct supervision of a qualified healthcare professional.
Disclaimer: Off-label use requires medical supervision and individualized risk assessment.
These effects are usually self-limiting and do not require specific treatment.
If you are taking other medicines, inform your healthcare provider before starting bromhexine.
Routine follow-up for patients on bromhexine includes:
If symptoms persist beyond a week or worsen, patients should contact their healthcare provider.
This article provides educational information about bromhexine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Bromhexine is intended for the treatment of existing mucus-related coughs, not for prophylactic use. Taking it before travel without a current respiratory symptom is not recommended.
In Hong Kong, 8 mg bromhexine tablets are commonly imprinted with the numeral “8” and the letter “B” on one side, though imprint configurations can vary by manufacturer.
Bromhexine is not a controlled substance and is not screened for in routine occupational drug-testing programs, including those for pilots.
Both are mucolytics, but bromhexine works by breaking disulfide bonds in mucus proteins, whereas guaifenesin primarily increases the volume of respiratory secretions to aid clearance.
Yes, there are no known pharmacokinetic conflicts; however, patients should still discuss all concurrent medications with their clinician.
If you miss a dose, take the next scheduled dose at the regular time; do not double up. If you suspect an overdose and develop severe symptoms, seek emergency medical care.
Bromhexine has not been associated with QT interval prolongation or other cardiac arrhythmias in standard clinical use.
When stored in a sealed container at room temperature, the tablets retain their potency until the printed expiration date, typically 2-3 years from manufacture.
St John’s wort induces CYP enzymes, potentially lowering bromhexine levels. Patients using such herbal products should inform their healthcare provider.
Bromhexine can be taken during non-fasting hours. If a dose is missed during the fasting period, it should be taken as soon as the fast is broken, without doubling the next dose.
